Virtual Tour
Media
NEWS
Contact Us
Patients
NEUROLOGY
CinnoVex
ReciGen
CinnoMer
CinnoTec
ONCOLOGY & HAEMATOLOGY
PegaGen
CinnaPoietin
KidiPeg
GYNECOLOGY & HORMONE
Cinnal-f
CinnaFact
CinnaTropin
Melitide
RHEUMATOLOGY
CinnoPar
CinnoRA
Healthcare Professionals
NEUROLOGY
CinnoVex
ReciGen
CinnoMer
CinnoTec
ONCOLOGY & HAEMATOLOGY
PegaGen
CinnaPoietin
KidiPeg
GYNECOLOGY & HORMONE
Cinnal-f
CinnaTropin
CinnaFact
Melitide
RHEUMATOLOGY
CinnoPar
CinnoRA
Capabilities
Our Technology
Business Development
Our Manufacturing Sites
Research and Development
About Us
Presidential Note
About CinnaGen
Mission Statement
Policy
Management Team
Search
Virtual Tour
Media
NEWS
Contact Us
Jan2019 / PR /
Previuos News
CinnaGen Sponsors IranPharma Expo
Next News
CinnaGen ilac has been established in 2019
tags:
CinnaGen
More in this category:
Launching the Iranian medicine "CinnoRA", in the presence of Minister of Health
26Oct 2016
Razi Research Festival on Medical Sciences
17Jan 2017
CinnaGen ilaç
20Jan 2017
CinnaGen obtained a Halal Certificate
30May 2018
CinnaGen Sponsors IranPharma Expo
23Sept. 2018
CinnaGen obtained GMP certification from EMA
24Feb. 2018
CinnaGen in Iraq Health care Exhibition
28June 2018
Cinnagen in Duphat
03Mar. 2018
Researchers announced safety and effectiveness of ReciGen (interferon beta-1a 44 mcg manufactured by CinnaGen Co.) on COVID-19 patients
20June 2020
Home
Happy New Year
Back top Top